VIDEO ACCESS:


RELEASE:  August 5, 2020
EXPIRATION: December 31, 2021 (Credit is not available after this expiration date.)

Learning Objectives:

  • Describe basic principles of Addiction Medicine and related epidemiology
  • Review substance use disorders (SUDs) commonly encountered in the inpatient Internal Medicine setting
  • Describe the various form of Medication Assisted Treatment (MAT) and the related pharmacology
  • Discuss the nuances and challenges of treating the acute ill patient comorbid substance use disorders.


Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Statement(s)
AMA
The Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1.0 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AAPA

Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This enduring material is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.



INSTRUCTIONS

  • Click the Start button below.
  • Participate in the quiz. Participants must pass by a minimum of 80%, 1 re-take is allowed. Quizzes have between 2-5 questions.
  • Complete the evaluation.


Listed below are individuals with control of the content of this program who have disclosed...
No relevant financial relationship(s) with industry:

Planning Committee:

Andy Herber PA-C – None
Abigail Meyers, PA-C – None
Elizabeth Nelson, APRN, CNP – None
Dr. Jamie Newman – None
Kyle Satterblom, PA-C – None
Amy Van Hoof – None

Dr. Robert Kirchoff - None

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
Dr. Robert Kirchoff: 
Gabapentin – I will be discussing off-label uses for treatment of symptoms related to post-acute withdrawal syndrome
Propranolol – For anxiety as a benzodiazepine sparing approach

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Dr. Robert Kirchoff
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota